Thursday 13 May 2021
Home      All news      Contact us      RSS      Chinese
todayonline - 23 days ago

Fujifilm starts new late-phase trial of Avigan in Japan for COVID-19 patients

TOKYO - Fujifilm Holdings Corp said on Wednesday it started a new phase III trial of its anti-influenza drug Avigan in Japan for COVID-19 patients. The new trial in Japan is targeting patients with early-onset of COVID-19 who have risk factors for progression to severe symptoms, Fujifilm said in a release. Domestic approval of the drug for COVID-19 was delayed after a health ministry panel said in December that trial data was inconclusive. REUTERS


Latest News
Hashtags:   

Fujifilm

 | 

starts

 | 

phase

 | 

trial

 | 

Avigan

 | 

Japan

 | 

COVID

 | 

patients

 | 

Sources